Chinese Clinical Oncology
• 论著 • Previous Articles Next Articles
ZHANG Shen,GONG Haibing,TAO Yuansheng.
Received:
Revised:
Online:
Published:
Abstract: Objective To explore the expression of PKM2 gene in breast cancer patients, and investigate the impact of PKM2 gene expression on prognosis of breast cancer. MethodsBioinformatics and free open gene chip dataset provided by Oncomine database and gene expression omnibus (GEO) database were used to analyze the expression of PKM2 gene in breast cancer patients. The relationship between PKM2 gene and prognosis of breast cancer was analyzed depending on PKM2 expression level. Results Expression level of PKM2 gene in breast cancer was significantly higher than that in normal breast tissue (P<0. 05). The diseasespecific survival rate of breast cancer patients with highexpression of PKM2 gene were significantly lower than those with lowexpression of PKM2 gene(HR=1.897,95%CI:1.117-3.221, P<0.05).The diseasefree survival time and the recurrencefree survival time of breast cancer patients with highexpression of PKM2 gene was significantly shorter than those with low-expression of PKM2 gene(HR=1.605, 95%CI:1.050-2.451, P=0.029; HR=7.377, 95%CI:1.906-28.548, P=0.004). Conclusion PKM2 gene is high expression in breast cancer, and the expression level of PKM2 has important significance in predicting the prognosis of breast cancer.
ZHANG Shen,GONG Haibing,TAO Yuansheng. . Prognostic analysis of PKM2 gene in breast cancer patients[J].Chinese Clinical Oncology, 2016, 21(11): 1005-.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://manu65.magtech.com.cn/Jwk3_lczlxzz/EN/
http://manu65.magtech.com.cn/Jwk3_lczlxzz/EN/Y2016/V21/I11/1005
Cited